Similarities and differences between multisystem inflammatory syndrome in children and Kawasaki disease – clinical presentations, laboratory features and treatment
DOI:
https://doi.org/10.12775/JEHS.2023.13.02.015Keywords
COVID 19, Kawasaki, MIS-C, SARS-CoV-2Abstract
Children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are mostly asymptomatic or have mild symptoms. However SARS-CoV-2 is also associated with a recently widely reported pediatric systemic vasculitis. This multisystem inflammatory syndrome in children (MIS-C) is still poorly understood, further information and studies are urgently needed. MIS-C has features that overlap with many known multisystem inflammatory diseases, especially Kawasaki disease. In this review, we are comparing MIS-C associated with COVID-19 and Kawasaki disease. We are searching for similarities and differences based on clinical manifestations, diagnosis, and treatment.
MIS-C jest stosunkowo nowym zespołem chorobowym, związanym z zakażeniem SARS-CoV-2. Nadal wymaga przeprowadzenia dalszych badań z perspektywy globalnej, w celu zrozumienia jego patogenezy, przebiegu i potencjalnych skutków. Chociaż objawy kliniczne MIS-C i KD mogą się pokrywać, wydają się być dwiema odrębnymi jednostkami klinicznymi i możemy spróbować je rozróżnić na podstawie objawów wspomnianych powyżej.
References
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13. PMID: 32410760; PMCID: PMC7220177.
https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children/symptoms.html
Cheung EW, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020;324:294–296.
Bukulmez H. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease. Curr Rheumatol Rep. 2021 Jul 3;23(8):58. doi: 10.1007/s11926-021-01028-4. PMID: 34216296; PMCID: PMC8254432.
McCrindle Brian W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–e999.
217. Abrams JY, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J. Pediatr. 2020;226:45–54.e1.
Cem E, Böncüoğlu E, Kıymet E, Şahinkaya Ş, Yılmaz Çelebi M, Gülderen M, Kaçar P, Akaslan Kara A, Aydın A, Murat M, Yılmazer MM, Bayram N, Devrim İ. Which Findings Make multisystem Inflammatory Syndrome in Children Different from the Pre-Pandemic Kawasaki Disease? Pediatr Cardiol. 2022 Jul 8:1–9. doi: 10.1007/s00246-022-02961-6. Epub ahead of print. PMID: 35804239; PMCID: PMC9282145.
Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children. Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. Erratum in: Front Immunol. 2021 Aug 05;12:722582. PMID: 33732254; PMCID: PMC7959769.
Riphagen S, Gomez X, Gonzales-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during Covid-19 pandemic. Lancet. (2020) 395:1607–8. 10.1016/S0140-6736(20)31094-1
About Kawasaki disease. Cdc.gov. May 29, 2020. https://www.cdc.gov/kawasaki/about.html
Medscape.org. 2022. https://www.medscape.org/viewarticle/724738 Published. Medscape.org. Accessed January 18, 2022. https://www.medscape.org/viewarticle/7247
Alsaied T., Tremoulet A.H., Burns J.C., et al. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation. 2021;143(1):78–88. doi: 10.1161/CIRCULATIONAHA.120.049836.
McCrindle B.W., Rowley A.H., Newburger J.W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi: 10.1161/CIR.0000000000000484.
Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. (2021) 39:3037–49. 10.1016/j.vaccine.2021.01.054
Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. (2021) 17:731–48. 10.1038/s41584-021-00709-9
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004. 110 (17): 2747– 71.
Kabeerdoss, J., Pilania, R.K., Karkhele, R. et al. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 41, 19–32 (2021). https://doi.org/10.1007/s00296-020-04749-4
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in Children in New York State. N Engl J Med. 2020;383(4):347–58.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al (2020) Multisystem inflammatory syndrome in US Children and adolescents. N Engl J Med 383(4):334–346
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H et al (2020) American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol.
Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG et al (2020) Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 41(7):1391–1401.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcin Czarkowski, Kamila Gorczyca, Maria Grodkiewicz, Aleksandra Słupczyńska, Weronika Urbaś, Klaudia Podgórska, Aleksandra Puła, Klaudia Artykiewicz, Urszula Krzysiek, Paweł Kozieł, Karolina Raksa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 416
Number of citations: 0